Search for: "Lisa Larrimore Ouellette"
Results 121 - 129
of 129
Sorted by Relevance
|
Sort by Date
12 Jan 2021, 9:04 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Why is HHS blocking FDA from regulating some diagnostics, and how will this affect COVID-19 testing?
25 Aug 2020, 4:50 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
4 Mar 2021, 10:50 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsAre patents the cause of—or solution to—COVID-19 vaccine innovation problems? [read post]
30 Mar 2020, 8:40 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowOne of the dizzying stream of innovation and health law stories to emerge last week is Oracle’s partnership with the White House to study unproven pharmaceuticals for treating COVID-19. [read post]
27 Apr 2018, 7:20 am
” I am indebted to my co-panelists Mark Lemley, David O’Brien, and Stefani Shanberg and to our moderator Lisa Larrimore Ouellette for sharpening my thinking on this developing issue. [read post]
1 Sep 2015, 3:52 am
By Jason Rantanen The Dow Chemical Company v. [read post]
6 Feb 2015, 6:00 am
Lisa Larrimore Ouellette (Stanford) (@PatentScholar) has created a Twitter list that makes it easier to follow all of the professors listed in the census. [read post]
11 Mar 2014, 7:56 pm
Camilla A. [read post]
24 Oct 2014, 1:11 pm
Measuring the degree to which brand asociations are held and how easily they are recalled can provide measures consistent w/the language of the law.Lisa Larrimore Ouellette (Stanford)Topic: Cognitive/Psychological Approaches to Modeling When and How Consumers Get Confused, Commenting on: Thomas R. [read post]
